A Non Profit Organization
EPEMED Luxembourg asbl is a non-profit organization under the Luxembourg law, registered in Luxembourg at 59, rue du dix Octobre, L-7243 Luxembourg Bereldange.
The organisation is directed by an Executive Director comprised of a dynamic and diverse group of European leaders in the personalised medicine field, who have great expertise in the application and development of diagnostic tools to deliver improved patient care.
Peter has been Vice President, Head of Diagnostics at GSK since Nov 2010. Peter leads GSK’s Diagnostic Nucleus focussed on supporting the diagnostic needs of GSK’s Clinical Development Programs across all business units.
Peter has over 30 years experience in the Diagnostics industry, specialising in Companion Diagnostics and Personalised Medicine, an area for which he has a real passion and commitment to see delivered.
Peter was formerly VP Pharma Business Development for Qiagen driving the uptake of personalized healthcare solutions in multiple partnerships across the pharma industry. Before this he was VP Business Development at DxS prior to its acquisition by QIAGEN in September 2009, , playing a pivotal role in securing a number of the company’s companion diagnostic agreements for KRAS and EGFR with key pharma clients. Peter was also VP of Marketing and Sales for Vysis Europe (now Abbott Molecular Diagnostics), where he lead the introduction PathVysion Her2 for selection of patients eligible for Herceptin in the EU.
Peter has an entrepreneurial background and held senior executive roles, including CEO, at a number of early stage diagnostics and life sciences companies including Quantase (Biorad), Gentronix, Biogenex and Pronostics. He began his commercial diagnostic career with Syva( Dade Behring/Bayer/Siemens) and BD’s Immunocytometry division. Peter started his career as a bench scientist in the NHS.